Top 20 Biotech VC Funds & Investors in Portugal (October 2023)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Portugal Ventures
VC Fund
|
8 | Portugal, United States, France | Seed, Pre-Seed | Software, Health Care, Information Technology | $107k–$1.6M |
|
Caixa Capital
VC Fund
|
6 | Portugal, United States, Spain | Seed, Series A | Software, Information Technology, Health Care | $107k–$24M |
|
Armilar Venture Partners
VC Fund
|
3 | Portugal, United States, United Kingdom | Series A, Seed | Software, Information Technology, Manufacturing | $482k–$12M |
|
Bynd Venture Capital
VC Fund
|
3 | Portugal, Spain, United States | Seed, Series A | Software, E-Commerce, Health Care | $465k–$3.5M |
|
Critical Ventures
VC Fund
|
2 | Portugal, United States | Seed, Series A | Medical, Computer, Genetics | |
|
InterCapital Group
VC Fund
|
1 | Portugal | Seed | Biofuel, Biotechnology | |
|
Shilling
VC Fund
|
1 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Internet, Information Technology, Software | $200k–$24M |
|
WISENEXT
VC Fund
|
1 | Portugal, United States | Seed, Pre-Seed | Software, Artificial Intelligence, Internet | $161k–$1.6M |
|
ChangePartners
VC Fund
|
1 | Portugal | Seed | Medical, Therapeutics, Biotechnology | |
|
Bionova Capital
VC Fund
|
1 | Portugal, United Kingdom | Seed | Biotechnology, Hospital, Health Care | $321k–$1.6M |
|
Ganexa Capital
VC Fund
|
1 | Portugal, United States, United Kingdom | Seed, Pre-Seed | Health Care, Fitness, Wellness | $482k–$2.6M |
|
Beta Capital
VC Fund
|
1 | Portugal | Seed | VoIP, Software, Wireless | |
|
Fairjourney Biologics
VC Fund
|
1 | Portugal | Corporate Round | Biotechnology | |
|
Boost VC
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Software, Virtual Reality, Blockchain | $70k–$4.4M |
|
Green Innovations
VC Fund
|
1 | Portugal | Series A | Medical, Genetics, Health Care | |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $70k–$12M |
|
Social Impact Fund
VC Fund
|
1 | Portugal, United States | Seed | Apps, Video, Medical | $951k–$2.5M |
|
StartUp Health
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$2.5M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Austria | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Medical | $573k–$21M |
|
InterCapital
VC Fund
|
1 | United Kingdom, Portugal | Seed | SaaS, Human Resources, Biofuel | |
| Access all 20 VC funds in Portugal Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Portugal Ventures is a venture capital firm that is part of the Banco Português de Fomento group, currently manages 170 million euros and has more than 130 portfolio companies. It invests in startups in the pre-seed, seed and series A stages that offer innovative solutions for the international market in the digital, engineering&industry, lifesciences, and tourism sectors. Since 2012, Portugal ventures has invested 164 million euros in 147 new businesses.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States, France
Investor stats
- Total investments: 159
- Round size: Seed $107k–$1.6M; Pre-Seed $107k–$643k
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
- MyCareforce — The platform that connects nurses to available shifts.
- Floating Particle — Floating Particle is a technology and innovation company that drives an innovative solution for waste management and clean energy. Floating Particle specializes in IoT, Big Data and Machine Learning to provide cutting-edge technology to the customers.
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 64
- Round size: Seed $107k–$2.5M; Series A $696k–$24M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
- Probely — Probely is a web application and API vulnerability scanner for agile teams. Automate Security Testing by adding Probely into your SDLC and CI/CD pipelines.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Seed
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 82
- Round size: Seed $482k–$2.7M; Series A $3.8M–$12M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Appentra — The first static code analyzer that increases the performance of C/C++ code. Write hardware-friendly code that runs faster on modern hardware.
- StudentFinance — Catapult your career with leading re-skilling and up-skilling bootcamps. Study now and pay us back once you land a job & start earning!
- Miles in the Sky — Embark on a journey with Miles to upgrade your learning experiences. Our unique model provides a better way to increase learner engagement and improve knowledge retention.
Bynd Venture Capital, former Busy Angels, is a Portuguese venture capital investor with more than 30 active investments in the portfolio in different funds. At Bynd Venture Capital we invest in companies: - At the seed / early stage - In IT/Digital and Sustainability (including Lifesciences, Clean Tech, among others) sectors - FromPortugal, Spain and any startup that has a direct connection with these markets (founders, tech team, investors, ...).
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 44
- Round size: Seed $465k–$3.5M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Trebellar — Trebellar provides advanced data analytics for building occupancy, energy efficiency, and climate optimization. Maximize your workplace productivity with our intelligent building solutions.
- Guud Woman — Verbeter je cyclus met Guud Woman. Onze supplementen ondersteunen je hormonen en vruchtbaarheid, bevorderen een gezonde huid en meer.
We invest in game-changing companies with the power to transform the way the world uses technology.
Show more...Investment focus
- Industry: Medical, Computer, Genetics
- Stage:Seed, Series A
- Geography: Portugal, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- hOS — hOS is an early-stage AI technology company.
- CBR Genomics — We are shaping the Future of Personalised Medicine
- Watchful Software — Watchful Software is focused on providing data-centric information protection that works. With the massive amounts that have been invested in securing the network perimeter, one thing has become painfully clear: today's enterprises must secure the information itself.
InterCapital Group provides management consulting and business advisory services to a wide range of companies, executives management teams and startups. We have the capacity to assist our clients in a variety of ways including business strategy, marketing plans, product development, angel investment or venture capital raises, social mediaconsulting, human resources, operational improvement, developing or strengthening a executive team or advisory board .The InterCapital Group typically works with clients and companies with less than $10 million on annual revenue. Current and past clients consist of companies from many sectors including financial services, consumer web, high-tech, software, mobile, media, communications, retail, hospitality, consumer products, consumer services, social media, nonprofits, insurance and wealth management.
Show more...Investment focus
- Industry: Biofuel, Biotechnology
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BioMimetx — BioMimetx is a biotech startup focused on the development of green antifouling solutions to prevent marine biofouling. The company discovers and owns environmental bacteria that secrete molecules, which are used as natural antimicrobials and algaecides. BioMimetx is based in Cantanhede, Portugal.
Shilling is an early-stage venture capital firm backing exceptional founders from the start.Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, directaccess to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Internet, Information Technology, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 56
- Round size: Seed $214k–$5M; Pre-Seed $200k–$3.2M; Series A $2.4M–$24M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Algori — Improving FMCG growth with the fastest and most granular insights from 45,000 shoppers in Spain
- Cargofive — Cargofive is the digital solution that will allow your freight forwarder to access to maritime rates from different providers in one place.
- MyCareforce — The platform that connects nurses to available shifts.
WiseNext is a venture and smart capital investment company. We focus on helping young entrepreneurs with innovative ideas that have an impact on our society, providing capital, knowledge and networking.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States
Investor stats
- Total investments: 13
- Round size: Seed $482k–$1.6M; Pre-Seed $161k–$429k
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Pleez — Pleez offers Restaurant's an optimisation of their menu within Delivery Platforms, so that they can have a revenue increase up to 25%.
- Reckon.ai — Reckon.ai have been working with several retail customers for the last years and they found that the task of competitive analysis in this vertical is still in the early days of what modern technology can do for them. You wouldn’t believe the number of problems and inefficiencies screaming for solutions in the digital age.So they decided to buildReckon, a cloud platform for smart retail product analysis and price comparison that uses powerful machine learning algorithms, data fusion and computer vision to reshape the way retailers get their competitive intelligence data.
- Relive — Relive is empowering the next generation of real estate entrepreneurs, with a mobile app that allows them to work for themselves, from anywhere, while saving time and earning commissions faster.
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. BionovaCapital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Show more...Investment focus
- Industry: Biotechnology, Hospital, Health Care
- Stage:Seed
- Geography: Portugal, United Kingdom
Investor stats
- Total investments: 4
- Round size: Seed $321k–$1.6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Delox — Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination.
- CellmAbs — Pharmaceutical Company, Biotechnology
- Adapttech — Adapttech is a biomedical company that uses innovative, smart and wearable technologies to deliver full adaptation and comfort to people with physical limitations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ability to open doors on opportunities (potential clients/strategic partners/suppliers/etc). Add market credibility, something missing in many start-ups.Know-how that can save you time, money and unnecessary stress and worry. Ability to complement the existing management team, filling gapsThey understand the difficulties andhardships of starting and building a business. They are motivated to work with you on the building process, and not just wait for the end result
Show more...Investment focus
- Industry: Health Care, Fitness, Wellness
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 7
- Round size: Seed $482k–$2.6M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Abtrace — Transforming Clinical Decisions through Data
- sheerME — SheerME is Revolutionising the way people find, book, and pay for their Wellness and Beauty services powered by a benefit-based walletOur approach is based on Discovery, Transaction & Reward to create more online visibility, reach, conversion into new business, loyalty, and frequency through our wallet and cashback ecosystem, to all ourpartners in the beauty and wellness sectors.This made us a fresh and different option in this sector where there are mainly SaaS players, and we bring marketplace with no monthly fee, only a commission for business sent through our owned and partner channels.
- ChemiTek — Certified & sustainable solutions for industrial maintenance. We have the solutions you need!
We support innovative tech ventures to unlock its potential by providing smart funding and hands-on advisory.
Show more...Investment focus
- Industry: VoIP, Software, Wireless
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nonius Hospitality Technology — Integrated Cloud Based Hospitality Technology Solutions to Enhance Guest Experiences with Chromecast, TV, Wi-Fi, App, Signage and Voice.
- Magnomics — Overview: Magnomics is a diagnostics, medical technology company committed to delivering a new generation of rapid, portable molecular diagnostic tests with applications in the human health, veterinary, and food industry markets. Affordable, disposable diagnostic cartridges will be produced in large scale and shipped via global distributors. Theteam behind the company has world class experience in biotechnology, electronics and physics, with a proven track record in managing start-ups. Magnomics has a Letter of Intent from a leading dairy company and won the 2015 Kansas City Animal Health Investment Forum innovation award, as well as the Ag Biotech Entrepreneurial Showcase award in North Carolina in 2016. €1.6M in seed financing have been raised through grants and investments. Magnomics is seeking €1.5M to conclude the prototyping of its first product in the animal health space. Technology: Magnomics technology stands on four patent families, with more in the pipeline, and has been published over twenty times in prestigious scientific journals. Magnomics provides a portable and affordable PCR device that requires no training to operate. The product integrates sample preparation, amplification and DNA detection within a single cartridge using microfluidics, making use of a novel magnetoresistive DNA sensing technology. Market: The veterinary diagnostics market is hungry for innovation and has low regulatory barriers. This market is estimated at €4 billion, with an 8.6% expected growth for the period 2016 to 2021. Magnomics will focus on the detection of bovine mastitis - an inflammation of the dairy cow’s mammary gland, whose treatment depends on the bacteria involved. This ailment causes over €30 billion in annual losses for producers worldwide. In the initial target markets (North America, Europe and Brazil), there are 56 million dairy cows with an average mastitis base incidence 30%. Given a €25 price tag and some segmentation, this amounts to a serviceable market of close to €300M, in which a penetration of 10-15% is expectable. The product can be sold either directly to farmers or to veterinarians: strategic partnerships are being negotiated with large pharma/dairy players to ensure market access.Competition: Companies such as AAD, DeLaval, and PortaCheck already have on-site solutions, which include California Mastitis Tests (CMT), Somatic Cell Counters and variants (SCC), as well as lateral flow strips. These current on-site diagnostics tools indicate the presence of an infection but are unable to determine the pathogen, which is key to define an appropriate treatment. Culture testing (e.g. Idexx, Virbac) is the current benchmark and is being tried on site as well: although cheap, the added value is greatly diminished due to long waiting times and difficulties in setting up a working protocol. Finally, laboratories provide fast molecular solutions (e.g. ThermoFisher) that are fast but expensive, while requiring complicated logistics due to sample collection that increase lead times. Magnomics will bring these molecular solutions to the farm in a convenient and affordable product.
FairJourney Biologics, a fee-for-service company, was founded in 2012 and has been profitable since 2013. The fast growth coupled to financial independence is a market validation of the excellence in antibody discovery and engineering and a guarantee of stable and strong partnerships.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Corporate Round
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Flow Eighteen38 — Flow Eighteen38 is to facilitate and accelerate antibody projects by delivering purified proteins.
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Virtual Reality, Blockchain
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 171
- Round size: Seed $405k–$4.4M; Pre-Seed $70k–$2.1M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- ShapesXR — ShapesXR is a provider of a web-based platform for content creation and collaboration for VR applications.
- Space DOTS — The first modular pico-labs for active in-space testing of advanced materials, from LEO to Cis-lunar and Interplanetary orbits.
- Cascade Biocatalysts — Cascade Biocatalysts is built on a novel way to immobilize enzymes. Our technology keeps enzymes active and stable under difficult industrial conditions.
International, Life Sciences, Biotechnology
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CBR Genomics — We are shaping the Future of Personalised Medicine
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 172
- Round size: Seed $96k–$2.4M; Pre-Seed $70k–$1.5M; Series A $3.3M–$12M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
- Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Industry: Apps, Video, Medical
- Stage:Seed
- Geography: Portugal, United States
Investor stats
- Total investments: 3
- Round size: Seed $951k–$2.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 140
- Round size: Seed $100k–$2.5M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Medwise.ai — Medwise.ai is the Google for doctors.
- Pear Suite — Pear Suite enables anyone—community health workers, other healthcare staff, and volunteers—to assess and address the social drivers of health for older adults in a scalable, cost-effective, and person-centered way.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Austria
Investor stats
- Total investments: 58
- Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
InterCapital is an investment firm focused on early-stage ventures. InterCapital cooperates with outstanding Entrepreneurs, promoting innovative ideas and business models, leading to positive social and environmental impact.
Show more...Investment focus
- Industry: SaaS, Human Resources, Biofuel
- Stage:Seed
- Geography: United Kingdom, Portugal
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Benivo — Increase satisfaction for employees and HR by >50% NPS. Save 30-70% on costs.
- Benivo — Increase satisfaction for employees and HR by >50% NPS. Save 30-70% on costs.
- BioMimetx — BioMimetx is a biotech startup focused on the development of green antifouling solutions to prevent marine biofouling. The company discovers and owns environmental bacteria that secrete molecules, which are used as natural antimicrobials and algaecides. BioMimetx is based in Cantanhede, Portugal.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Portugal investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Portugal Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!